Clicky

Tuesday, November 17, 2026

Markets

Rates, jobs, and market-wide news

Helus Pharma Appoints Dr. Suresh Durgam to Board of Directors

Helus Pharma Inc. strengthens its leadership by appointing Dr. Suresh Durgam to its Board, enhancing its focus on mental health therapies.

Cementos Pacasmayo discloses valuation report for tender offer

Cementos Pacasmayo has released a valuation report related to a tender offer, impacting the hydraulic cement industry and its competitors.

LG Display Reports Allegations of Embezzlement by Former Officer

LG Display Co., Ltd. disclosed allegations of embezzlement by a former officer, impacting its reputation and the electronic components industry.

Avino Silver & Gold Mines Reports Q3 2026 Production Results

Avino Silver & Gold Mines Ltd. announces strong Q3 2026 production results with increased silver output, highlighting growth at La Preciosa project.

Brookfield Renewable shareholders approve key transaction

Brookfield Renewable Corp's shareholders approve a significant transaction, signaling a strategic shift in the electric services sector.

Brookfield Infrastructure Partners approves key resolutions

Brookfield Infrastructure Partners L.P. announces the approval of key resolutions at a special unitholders' meeting, signaling strategic growth in water transportation.

Black Mammoth Metals to List on Nasdaq Capital Market

Black Mammoth Metals Corp receives approval to list on Nasdaq, enhancing visibility and access to a broader investor base. Trading begins October 15, 2026.

Cementos Pacasmayo Announces Tender Offer from Holcim Ltd.

Cementos Pacasmayo SAA reveals a tender offer from Holcim Ltd., impacting its share structure and highlighting competition in the hydraulic cement industry.

AMBEV S.A. Confirms Appointment of Logistics Vice President

AMBEV S.A. confirms Fernando Maffessoni as Vice President of Logistics, effective September 1, 2026, enhancing its operational strategy.

VS MEDIA Holdings approves restructuring and name change

VS MEDIA Holdings Ltd has approved a restructuring plan and will change its name to Forcendra Holding Limited, focusing on divesting loss-making operations.

Banco Santander to Redeem $298.4M in Preferred Securities

Banco Santander, S.A. plans to redeem $298.4 million in preferred securities, signaling strategic financial management within the commercial banking sector.

Mayfair Gold Corp. Completes Strategic Investment with Macquarie

Mayfair Gold Corp. announces completion of a strategic investment with Macquarie Bank, raising C$10 million for the Fenn-Gib gold project.

Biodexa enrolls 100 patients in Phase 3 trial for eRapa

Biodexa Pharmaceuticals enrolls 100 patients in its Phase 3 trial for eRapa, a significant milestone in treating Familial Adenomatous Polyposis.

Inter & Co announces senior leadership changes to boost growth

Inter & Co, Inc. announces a new leadership structure with Francisco Santos as Chief Growth Officer and Alexandre Riccio as COO and Executive Vice Chairman.

XCHG Ltd Addresses Recent Share Price Volatility

XCHG Ltd issues a statement on stock price fluctuations, reaffirming confidence in its business fundamentals and growth potential.

Evotec SE exceeds expectations with preliminary results

Evotec SE announces preliminary nine-month results for 2026, surpassing market expectations and reaffirming its full-year guidance.

IsoEnergy appoints Nathan Bridge as VP of Exploration

IsoEnergy Ltd. announces Nathan Bridge as VP of Exploration and Dr. Dan Brisbin as VP of Geology, aiming to enhance uranium exploration efforts.

Diageo announces restated regional financial results

Diageo PLC has published restated financial results for fiscal years 2025 and 2026, aligning with a new market framework.

Fortuna Mining reports promising exploration results in Senegal

Fortuna Mining Corp. announces encouraging exploration results from its Diamba Sud Gold Project, signaling potential for increased mineral reserves.

NovaBridge Biosciences Enters License Agreement for VIS-102

NovaBridge Biosciences has secured a license for VIS-102, a new therapy for neurotrophic keratitis, enhancing its ophthalmology pipeline.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →